Stereotaxis (STXS) Cash & Equivalents (2010 - 2026)

Stereotaxis (STXS) has reported Cash & Equivalents for 17 consecutive years, with $14.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 37.87% year-over-year to $14.6 million; the TTM figure through Mar 2026 stood at $14.6 million (up 37.87% YoY), while the FY2025 annual figure was $13.4 million, up 9.86% from the prior year.
• Cash & Equivalents grew to $14.6 million in Q1 2026 per STXS's latest filing, from $13.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $36.9 million in Q1 2022 and bottomed at $6.8 million in Q1 2023.
• Historically, Cash & Equivalents has averaged $18.8 million across 5 years, with a median of $15.2 million in 2024.
• Annual changes were most pronounced in 2023 — Cash & Equivalents plunged 81.66% — and 2024, when it soared 169.91%.
• Stereotaxis' Cash & Equivalents stood at $29.7 million in 2022, then tumbled by 30.77% to $20.6 million in 2023, then slumped by 40.58% to $12.2 million in 2024, then increased by 9.86% to $13.4 million in 2025, then rose by 8.9% to $14.6 million in 2026.
• Business Quant data shows STXS's Cash & Equivalents at $14.6 million in Q1 2026, $13.4 million in Q4 2025, and $10.5 million in Q3 2025.